Core Viewpoint - The company has signed a distribution agreement with Guangzhou Junxin Pharmaceutical Co., Ltd. for the exclusive promotion, sale, and distribution of the product Anbomei® in a specific market during the agreement period [1] Summary by Relevant Sections - Agreement Details - The agreement grants the company exclusive rights to promote, sell, and distribute Anbomei® in the designated market [1] - The agreement is effective from November 4, 2025, to June 30, 2035 [1] - Minimum Purchase Requirements - For the period from 2025 to 2026, the minimum annual purchase volume is set at 4.5 million bottles [1] - For the period from 2026 to 2027, the minimum annual purchase volume increases to 5 million bottles [1] - For the period from 2027 to 2028, the minimum annual purchase volume further increases to 5.5 million bottles [1]
百洋医药：签署经销协议，经销商年度最低采购量为450万瓶